UK biotech sees worst funding downturn since 2012
pharmaphorum
JANUARY 27, 2023
Indeed, Initial Public Offerings (IPOs) raised just £28 million – the worst annual haul since 2012 – and, during the entirety of last year, UK biotech raised just £1.8 On the report’s findings, Steve Bates OBE, CEO of the BIA, said: “UK-based life sciences companies are worldleading in developing life changing medical innovation.
Let's personalize your content